nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—Propranolol—hypertension	0.248	1	CrCtD
Naphazoline—NISCH—hypertension	0.12	0.51	CbGaD
Naphazoline—ADRA2B—hypertension	0.0562	0.238	CbGaD
Naphazoline—NISCH—Guanabenz—hypertension	0.045	0.181	CbGbCtD
Naphazoline—NISCH—Guanfacine—hypertension	0.0418	0.168	CbGbCtD
Naphazoline—Terbinafine—Propranolol—hypertension	0.039	0.226	CrCrCtD
Naphazoline—ADRA1A—hypertension	0.0348	0.147	CbGaD
Naphazoline—ADRA2A—hypertension	0.0246	0.104	CbGaD
Naphazoline—NISCH—Clonidine—hypertension	0.0204	0.0821	CbGbCtD
Naphazoline—Duloxetine—Propranolol—hypertension	0.0204	0.118	CrCrCtD
Naphazoline—Propranolol—Carvedilol—hypertension	0.0169	0.0975	CrCrCtD
Naphazoline—Antazoline—Bepridil—hypertension	0.016	0.0924	CrCrCtD
Naphazoline—Propranolol—Acebutolol—hypertension	0.0156	0.0899	CrCrCtD
Naphazoline—Propranolol—Metoprolol—hypertension	0.0141	0.0817	CrCrCtD
Naphazoline—Propranolol—Esmolol—hypertension	0.0134	0.0774	CrCrCtD
Naphazoline—Propranolol—Pindolol—hypertension	0.0131	0.0756	CrCrCtD
Naphazoline—Propranolol—Penbutolol—hypertension	0.0128	0.0739	CrCrCtD
Naphazoline—Propranolol—Betaxolol—hypertension	0.0118	0.0682	CrCrCtD
Naphazoline—ADRA2C—Guanabenz—hypertension	0.0103	0.0415	CbGbCtD
Naphazoline—ADRA2B—Guanabenz—hypertension	0.0098	0.0394	CbGbCtD
Naphazoline—ADRA2B—Guanfacine—hypertension	0.00911	0.0366	CbGbCtD
Naphazoline—ADRA2C—Fenoldopam—hypertension	0.00817	0.0328	CbGbCtD
Naphazoline—ADRA2B—Fenoldopam—hypertension	0.00775	0.0311	CbGbCtD
Naphazoline—ADRA2A—Methyldopa—hypertension	0.00745	0.03	CbGbCtD
Naphazoline—ADRA2A—Guanabenz—hypertension	0.00682	0.0274	CbGbCtD
Naphazoline—ADRA2A—Guanfacine—hypertension	0.00634	0.0255	CbGbCtD
Naphazoline—ADRA2B—Prazosin—hypertension	0.00587	0.0236	CbGbCtD
Naphazoline—ADRA1A—Terazosin—hypertension	0.00571	0.023	CbGbCtD
Naphazoline—ADRA2A—Fenoldopam—hypertension	0.00539	0.0217	CbGbCtD
Naphazoline—ADRA2C—Carvedilol—hypertension	0.00534	0.0215	CbGbCtD
Naphazoline—ADRA1A—Fenoldopam—hypertension	0.00517	0.0208	CbGbCtD
Naphazoline—ADRA2B—Carvedilol—hypertension	0.00507	0.0204	CbGbCtD
Naphazoline—ADRA2A—Doxazosin—hypertension	0.00497	0.02	CbGbCtD
Naphazoline—ADRA1A—Doxazosin—hypertension	0.00477	0.0192	CbGbCtD
Naphazoline—ADRA2C—Clonidine—hypertension	0.00469	0.0189	CbGbCtD
Naphazoline—ADRA2B—Clonidine—hypertension	0.00445	0.0179	CbGbCtD
Naphazoline—ADRA2A—Prazosin—hypertension	0.00408	0.0164	CbGbCtD
Naphazoline—ADRA1A—Prazosin—hypertension	0.00392	0.0157	CbGbCtD
Naphazoline—ADRA2A—Carvedilol—hypertension	0.00353	0.0142	CbGbCtD
Naphazoline—ADRA1A—Nicardipine—hypertension	0.00338	0.0136	CbGbCtD
Naphazoline—ADRA1A—Carvedilol—hypertension	0.00338	0.0136	CbGbCtD
Naphazoline—ADRA2A—Clonidine—hypertension	0.0031	0.0124	CbGbCtD
Naphazoline—ADRA1A—Clonidine—hypertension	0.00297	0.0119	CbGbCtD
Naphazoline—Phentolamine—NISCH—hypertension	0.000394	0.216	CrCbGaD
Naphazoline—NISCH—myocardium—hypertension	0.000387	0.0749	CbGeAlD
Naphazoline—NISCH—nephron tubule—hypertension	0.000284	0.0549	CbGeAlD
Naphazoline—NISCH—adrenal cortex—hypertension	0.00028	0.054	CbGeAlD
Naphazoline—NISCH—heart—hypertension	0.00027	0.0523	CbGeAlD
Naphazoline—NISCH—smooth muscle tissue—hypertension	0.000268	0.0518	CbGeAlD
Naphazoline—NISCH—decidua—hypertension	0.000263	0.0508	CbGeAlD
Naphazoline—Duloxetine—NPY1R—hypertension	0.000258	0.141	CrCbGaD
Naphazoline—NISCH—cortex of kidney—hypertension	0.000243	0.047	CbGeAlD
Naphazoline—NISCH—medulla oblongata—hypertension	0.000218	0.0421	CbGeAlD
Naphazoline—NISCH—adrenal gland—hypertension	0.000202	0.039	CbGeAlD
Naphazoline—ADRA2C—cardiac ventricle—hypertension	0.000188	0.0364	CbGeAlD
Naphazoline—Phentolamine—ADRA2B—hypertension	0.000184	0.101	CrCbGaD
Naphazoline—ADRA2C—myocardium—hypertension	0.000177	0.0342	CbGeAlD
Naphazoline—ADRA1A—brainstem—hypertension	0.00015	0.029	CbGeAlD
Naphazoline—ADRA2C—nephron tubule—hypertension	0.00013	0.0251	CbGeAlD
Naphazoline—ADRA1A—heart—hypertension	0.00013	0.025	CbGeAlD
Naphazoline—ADRA2C—adrenal cortex—hypertension	0.000128	0.0247	CbGeAlD
Naphazoline—Terbinafine—CYP11A1—hypertension	0.000124	0.0681	CrCbGaD
Naphazoline—ADRA2C—heart—hypertension	0.000123	0.0239	CbGeAlD
Naphazoline—ADRA1A—cardiovascular system—hypertension	0.000122	0.0236	CbGeAlD
Naphazoline—ADRA2C—decidua—hypertension	0.00012	0.0232	CbGeAlD
Naphazoline—ADRA2C—kidney—hypertension	0.000114	0.022	CbGeAlD
Naphazoline—Phentolamine—ADRA1A—hypertension	0.000114	0.0623	CrCbGaD
Naphazoline—ADRA2C—cortex of kidney—hypertension	0.000111	0.0215	CbGeAlD
Naphazoline—Tolazoline—ADRA2B—hypertension	0.000108	0.0593	CrCbGaD
Naphazoline—ADRA2C—cardiac atrium—hypertension	0.000106	0.0204	CbGeAlD
Naphazoline—ADRA2C—medulla oblongata—hypertension	9.96e-05	0.0192	CbGeAlD
Naphazoline—Duloxetine—SLC6A2—hypertension	9.93e-05	0.0544	CrCbGaD
Naphazoline—ADRA2A—heart—hypertension	9.85e-05	0.019	CbGeAlD
Naphazoline—ADRA1A—adrenal gland—hypertension	9.67e-05	0.0187	CbGeAlD
Naphazoline—ADRA2A—decidua—hypertension	9.58e-05	0.0185	CbGeAlD
Naphazoline—ADRA2C—adrenal gland—hypertension	9.22e-05	0.0178	CbGeAlD
Naphazoline—ADRA2A—cortex of kidney—hypertension	8.86e-05	0.0171	CbGeAlD
Naphazoline—ADRA2A—cardiac atrium—hypertension	8.43e-05	0.0163	CbGeAlD
Naphazoline—ADRA1A—endocrine gland—hypertension	8.39e-05	0.0162	CbGeAlD
Naphazoline—Phentolamine—ADRA2A—hypertension	8.06e-05	0.0441	CrCbGaD
Naphazoline—ADRA2A—medulla oblongata—hypertension	7.94e-05	0.0154	CbGeAlD
Naphazoline—ADRA1A—central nervous system—hypertension	7.56e-05	0.0146	CbGeAlD
Naphazoline—ADRA2A—adrenal gland—hypertension	7.35e-05	0.0142	CbGeAlD
Naphazoline—ADRA2C—central nervous system—hypertension	7.2e-05	0.0139	CbGeAlD
Naphazoline—Tolazoline—ADRA1A—hypertension	6.71e-05	0.0367	CrCbGaD
Naphazoline—Terbinafine—CYP19A1—hypertension	6.43e-05	0.0352	CrCbGaD
Naphazoline—ADRA2A—endocrine gland—hypertension	6.38e-05	0.0123	CbGeAlD
Naphazoline—ADRA2A—central nervous system—hypertension	5.75e-05	0.0111	CbGeAlD
Naphazoline—Terbinafine—PTGS1—hypertension	5.17e-05	0.0283	CrCbGaD
Naphazoline—Duloxetine—SLC6A3—hypertension	5.05e-05	0.0277	CrCbGaD
Naphazoline—Dizziness—Isradipine—hypertension	4.97e-05	0.000978	CcSEcCtD
Naphazoline—Asthenia—Acebutolol—hypertension	4.97e-05	0.000978	CcSEcCtD
Naphazoline—Headache—Pindolol—hypertension	4.97e-05	0.000976	CcSEcCtD
Naphazoline—Hyperhidrosis—Verapamil—hypertension	4.96e-05	0.000975	CcSEcCtD
Naphazoline—Somnolence—Propranolol—hypertension	4.96e-05	0.000974	CcSEcCtD
Naphazoline—Dizziness—Guanfacine—hypertension	4.96e-05	0.000974	CcSEcCtD
Naphazoline—Tension—Perindopril—hypertension	4.95e-05	0.000973	CcSEcCtD
Naphazoline—Dizziness—Nicardipine—hypertension	4.94e-05	0.00097	CcSEcCtD
Naphazoline—Tension—Irbesartan—hypertension	4.94e-05	0.00097	CcSEcCtD
Naphazoline—Asthenia—Labetalol—hypertension	4.93e-05	0.000969	CcSEcCtD
Naphazoline—Nausea—Candesartan—hypertension	4.93e-05	0.000968	CcSEcCtD
Naphazoline—Erythema—Furosemide—hypertension	4.91e-05	0.000964	CcSEcCtD
Naphazoline—Nervousness—Perindopril—hypertension	4.9e-05	0.000963	CcSEcCtD
Naphazoline—Discomfort—Olmesartan—hypertension	4.9e-05	0.000963	CcSEcCtD
Naphazoline—Vision blurred—Captopril—hypertension	4.9e-05	0.000963	CcSEcCtD
Naphazoline—Tension—Hydrochlorothiazide—hypertension	4.9e-05	0.000962	CcSEcCtD
Naphazoline—Nervousness—Irbesartan—hypertension	4.89e-05	0.00096	CcSEcCtD
Naphazoline—Dizziness—Metolazone—hypertension	4.88e-05	0.00096	CcSEcCtD
Naphazoline—Dizziness—Felodipine—hypertension	4.88e-05	0.00096	CcSEcCtD
Naphazoline—Headache—Quinapril—hypertension	4.88e-05	0.00096	CcSEcCtD
Naphazoline—Sweating—Timolol—hypertension	4.87e-05	0.000957	CcSEcCtD
Naphazoline—Dizziness—Spironolactone—hypertension	4.87e-05	0.000956	CcSEcCtD
Naphazoline—Nausea—Methyldopa—hypertension	4.86e-05	0.000955	CcSEcCtD
Naphazoline—Erythema—Betaxolol—hypertension	4.86e-05	0.000955	CcSEcCtD
Naphazoline—Nervousness—Hydrochlorothiazide—hypertension	4.85e-05	0.000952	CcSEcCtD
Naphazoline—Headache—Benazepril—hypertension	4.81e-05	0.000944	CcSEcCtD
Naphazoline—Somnolence—Diltiazem—hypertension	4.8e-05	0.000943	CcSEcCtD
Naphazoline—Somnolence—Indapamide—hypertension	4.8e-05	0.000943	CcSEcCtD
Naphazoline—Asthenia—Eprosartan—hypertension	4.78e-05	0.000938	CcSEcCtD
Naphazoline—Nausea—Amiloride—hypertension	4.77e-05	0.000938	CcSEcCtD
Naphazoline—Nausea—Hydralazine—hypertension	4.77e-05	0.000938	CcSEcCtD
Naphazoline—Tension—Betaxolol—hypertension	4.77e-05	0.000937	CcSEcCtD
Naphazoline—Dizziness—Esmolol—hypertension	4.77e-05	0.000937	CcSEcCtD
Naphazoline—Hyperglycaemia—Lisinopril—hypertension	4.77e-05	0.000937	CcSEcCtD
Naphazoline—Somnolence—Carvedilol—hypertension	4.75e-05	0.000934	CcSEcCtD
Naphazoline—Tolazoline—ADRA2A—hypertension	4.75e-05	0.026	CrCbGaD
Naphazoline—Vision blurred—Irbesartan—hypertension	4.74e-05	0.000932	CcSEcCtD
Naphazoline—Erythema—Losartan—hypertension	4.73e-05	0.00093	CcSEcCtD
Naphazoline—Nervousness—Betaxolol—hypertension	4.72e-05	0.000927	CcSEcCtD
Naphazoline—Headache—Isradipine—hypertension	4.71e-05	0.000926	CcSEcCtD
Naphazoline—Nausea—Pindolol—hypertension	4.71e-05	0.000925	CcSEcCtD
Naphazoline—Dizziness—Terazosin—hypertension	4.7e-05	0.000924	CcSEcCtD
Naphazoline—Vision blurred—Hydrochlorothiazide—hypertension	4.7e-05	0.000924	CcSEcCtD
Naphazoline—Somnolence—Doxazosin—hypertension	4.7e-05	0.000924	CcSEcCtD
Naphazoline—Headache—Guanfacine—hypertension	4.7e-05	0.000923	CcSEcCtD
Naphazoline—Discomfort—Clonidine—hypertension	4.69e-05	0.000922	CcSEcCtD
Naphazoline—Headache—Nicardipine—hypertension	4.68e-05	0.000919	CcSEcCtD
Naphazoline—Tension—Losartan—hypertension	4.64e-05	0.000913	CcSEcCtD
Naphazoline—Somnolence—Fosinopril—hypertension	4.64e-05	0.000912	CcSEcCtD
Naphazoline—Asthenia—Amlodipine—hypertension	4.64e-05	0.000911	CcSEcCtD
Naphazoline—Nausea—Quinapril—hypertension	4.63e-05	0.00091	CcSEcCtD
Naphazoline—Headache—Felodipine—hypertension	4.63e-05	0.000909	CcSEcCtD
Naphazoline—Headache—Metolazone—hypertension	4.63e-05	0.000909	CcSEcCtD
Naphazoline—Vision blurred—Furosemide—hypertension	4.62e-05	0.000909	CcSEcCtD
Naphazoline—Hypertension—Telmisartan—hypertension	4.61e-05	0.000907	CcSEcCtD
Naphazoline—Headache—Spironolactone—hypertension	4.61e-05	0.000906	CcSEcCtD
Naphazoline—Nervousness—Losartan—hypertension	4.6e-05	0.000903	CcSEcCtD
Naphazoline—Hyperhidrosis—Olmesartan—hypertension	4.6e-05	0.000903	CcSEcCtD
Naphazoline—Dizziness—Acebutolol—hypertension	4.58e-05	0.000901	CcSEcCtD
Naphazoline—Somnolence—Nifedipine—hypertension	4.58e-05	0.0009	CcSEcCtD
Naphazoline—Vision blurred—Betaxolol—hypertension	4.58e-05	0.0009	CcSEcCtD
Naphazoline—Discomfort—Trandolapril—hypertension	4.58e-05	0.000899	CcSEcCtD
Naphazoline—Somnolence—Verapamil—hypertension	4.56e-05	0.000896	CcSEcCtD
Naphazoline—Discomfort—Enalapril—hypertension	4.56e-05	0.000896	CcSEcCtD
Naphazoline—Nausea—Benazepril—hypertension	4.56e-05	0.000895	CcSEcCtD
Naphazoline—Dizziness—Labetalol—hypertension	4.54e-05	0.000893	CcSEcCtD
Naphazoline—Nausea—Nadolol—hypertension	4.54e-05	0.000892	CcSEcCtD
Naphazoline—Sweating—Lisinopril—hypertension	4.52e-05	0.000887	CcSEcCtD
Naphazoline—Headache—Esmolol—hypertension	4.52e-05	0.000887	CcSEcCtD
Naphazoline—Discomfort—Telmisartan—hypertension	4.5e-05	0.000884	CcSEcCtD
Naphazoline—Nausea—Isradipine—hypertension	4.47e-05	0.000878	CcSEcCtD
Naphazoline—Vision blurred—Losartan—hypertension	4.46e-05	0.000877	CcSEcCtD
Naphazoline—Headache—Terazosin—hypertension	4.46e-05	0.000876	CcSEcCtD
Naphazoline—Nausea—Guanfacine—hypertension	4.45e-05	0.000875	CcSEcCtD
Naphazoline—Nausea—Nicardipine—hypertension	4.44e-05	0.000872	CcSEcCtD
Naphazoline—Hyperhidrosis—Clonidine—hypertension	4.4e-05	0.000865	CcSEcCtD
Naphazoline—Dizziness—Eprosartan—hypertension	4.4e-05	0.000865	CcSEcCtD
Naphazoline—Nausea—Metolazone—hypertension	4.39e-05	0.000862	CcSEcCtD
Naphazoline—Nausea—Felodipine—hypertension	4.39e-05	0.000862	CcSEcCtD
Naphazoline—Discomfort—Captopril—hypertension	4.37e-05	0.000859	CcSEcCtD
Naphazoline—Nausea—Spironolactone—hypertension	4.37e-05	0.000859	CcSEcCtD
Naphazoline—Asthenia—Guanabenz—hypertension	4.36e-05	0.000856	CcSEcCtD
Naphazoline—Asthenia—Metoprolol—hypertension	4.36e-05	0.000856	CcSEcCtD
Naphazoline—Hypertension—Perindopril—hypertension	4.36e-05	0.000856	CcSEcCtD
Naphazoline—Headache—Acebutolol—hypertension	4.34e-05	0.000854	CcSEcCtD
Naphazoline—Hypertension—Irbesartan—hypertension	4.34e-05	0.000853	CcSEcCtD
Naphazoline—Headache—Labetalol—hypertension	4.3e-05	0.000846	CcSEcCtD
Naphazoline—Hyperhidrosis—Trandolapril—hypertension	4.29e-05	0.000844	CcSEcCtD
Naphazoline—Nausea—Esmolol—hypertension	4.28e-05	0.000841	CcSEcCtD
Naphazoline—Hyperhidrosis—Enalapril—hypertension	4.28e-05	0.00084	CcSEcCtD
Naphazoline—Dizziness—Amlodipine—hypertension	4.27e-05	0.00084	CcSEcCtD
Naphazoline—Dizziness—Nisoldipine—hypertension	4.27e-05	0.00084	CcSEcCtD
Naphazoline—Eye disorder—Timolol—hypertension	4.26e-05	0.000837	CcSEcCtD
Naphazoline—Somnolence—Valsartan—hypertension	4.25e-05	0.000835	CcSEcCtD
Naphazoline—Discomfort—Perindopril—hypertension	4.24e-05	0.000834	CcSEcCtD
Naphazoline—Discomfort—Irbesartan—hypertension	4.23e-05	0.000831	CcSEcCtD
Naphazoline—Nausea—Terazosin—hypertension	4.22e-05	0.00083	CcSEcCtD
Naphazoline—Hyperhidrosis—Telmisartan—hypertension	4.22e-05	0.000829	CcSEcCtD
Naphazoline—Discomfort—Hydrochlorothiazide—hypertension	4.2e-05	0.000825	CcSEcCtD
Naphazoline—Headache—Eprosartan—hypertension	4.17e-05	0.000819	CcSEcCtD
Naphazoline—Nausea—Acebutolol—hypertension	4.12e-05	0.000809	CcSEcCtD
Naphazoline—Discomfort—Betaxolol—hypertension	4.09e-05	0.000803	CcSEcCtD
Naphazoline—Nausea—Labetalol—hypertension	4.08e-05	0.000802	CcSEcCtD
Naphazoline—Erythema—Ramipril—hypertension	4.06e-05	0.000798	CcSEcCtD
Naphazoline—Headache—Amlodipine—hypertension	4.05e-05	0.000796	CcSEcCtD
Naphazoline—Headache—Nisoldipine—hypertension	4.05e-05	0.000796	CcSEcCtD
Naphazoline—Somnolence—Clonidine—hypertension	4.05e-05	0.000795	CcSEcCtD
Naphazoline—Dizziness—Guanabenz—hypertension	4.02e-05	0.000789	CcSEcCtD
Naphazoline—Dizziness—Metoprolol—hypertension	4.02e-05	0.000789	CcSEcCtD
Naphazoline—Asthenia—Propranolol—hypertension	4e-05	0.000786	CcSEcCtD
Naphazoline—Tension—Ramipril—hypertension	3.98e-05	0.000783	CcSEcCtD
Naphazoline—Hyperhidrosis—Perindopril—hypertension	3.98e-05	0.000782	CcSEcCtD
Naphazoline—Discomfort—Losartan—hypertension	3.98e-05	0.000782	CcSEcCtD
Naphazoline—Hyperhidrosis—Irbesartan—hypertension	3.97e-05	0.00078	CcSEcCtD
Naphazoline—Erythema—Timolol—hypertension	3.97e-05	0.00078	CcSEcCtD
Naphazoline—Nausea—Eprosartan—hypertension	3.95e-05	0.000777	CcSEcCtD
Naphazoline—Somnolence—Trandolapril—hypertension	3.95e-05	0.000776	CcSEcCtD
Naphazoline—Nervousness—Ramipril—hypertension	3.94e-05	0.000775	CcSEcCtD
Naphazoline—Hyperhidrosis—Hydrochlorothiazide—hypertension	3.94e-05	0.000773	CcSEcCtD
Naphazoline—Somnolence—Enalapril—hypertension	3.93e-05	0.000773	CcSEcCtD
Naphazoline—Tension—Timolol—hypertension	3.89e-05	0.000765	CcSEcCtD
Naphazoline—Somnolence—Telmisartan—hypertension	3.88e-05	0.000762	CcSEcCtD
Naphazoline—Asthenia—Indapamide—hypertension	3.87e-05	0.000761	CcSEcCtD
Naphazoline—Asthenia—Diltiazem—hypertension	3.87e-05	0.000761	CcSEcCtD
Naphazoline—Hyperhidrosis—Furosemide—hypertension	3.87e-05	0.000761	CcSEcCtD
Naphazoline—Nervousness—Timolol—hypertension	3.85e-05	0.000757	CcSEcCtD
Naphazoline—Nausea—Nisoldipine—hypertension	3.84e-05	0.000754	CcSEcCtD
Naphazoline—Nausea—Amlodipine—hypertension	3.84e-05	0.000754	CcSEcCtD
Naphazoline—Asthenia—Carvedilol—hypertension	3.84e-05	0.000754	CcSEcCtD
Naphazoline—Hyperhidrosis—Betaxolol—hypertension	3.83e-05	0.000753	CcSEcCtD
Naphazoline—Headache—Guanabenz—hypertension	3.8e-05	0.000748	CcSEcCtD
Naphazoline—Headache—Metoprolol—hypertension	3.8e-05	0.000748	CcSEcCtD
Naphazoline—Asthenia—Doxazosin—hypertension	3.79e-05	0.000746	CcSEcCtD
Naphazoline—Duloxetine—SLC6A4—hypertension	3.78e-05	0.0207	CrCbGaD
Naphazoline—Somnolence—Captopril—hypertension	3.77e-05	0.000741	CcSEcCtD
Naphazoline—Asthenia—Fosinopril—hypertension	3.75e-05	0.000736	CcSEcCtD
Naphazoline—Vision blurred—Timolol—hypertension	3.74e-05	0.000735	CcSEcCtD
Naphazoline—Hyperhidrosis—Losartan—hypertension	3.73e-05	0.000734	CcSEcCtD
Naphazoline—Asthenia—Eplerenone—hypertension	3.72e-05	0.000732	CcSEcCtD
Naphazoline—Asthenia—Nifedipine—hypertension	3.7e-05	0.000727	CcSEcCtD
Naphazoline—Dizziness—Propranolol—hypertension	3.69e-05	0.000725	CcSEcCtD
Naphazoline—Asthenia—Verapamil—hypertension	3.68e-05	0.000723	CcSEcCtD
Naphazoline—Erythema—Lisinopril—hypertension	3.68e-05	0.000723	CcSEcCtD
Naphazoline—Somnolence—Perindopril—hypertension	3.66e-05	0.00072	CcSEcCtD
Naphazoline—Somnolence—Irbesartan—hypertension	3.65e-05	0.000717	CcSEcCtD
Naphazoline—Somnolence—Hydrochlorothiazide—hypertension	3.62e-05	0.000711	CcSEcCtD
Naphazoline—Tension—Lisinopril—hypertension	3.61e-05	0.00071	CcSEcCtD
Naphazoline—Nausea—Guanabenz—hypertension	3.61e-05	0.000709	CcSEcCtD
Naphazoline—Nausea—Metoprolol—hypertension	3.61e-05	0.000709	CcSEcCtD
Naphazoline—Nervousness—Lisinopril—hypertension	3.58e-05	0.000703	CcSEcCtD
Naphazoline—Dizziness—Indapamide—hypertension	3.57e-05	0.000702	CcSEcCtD
Naphazoline—Dizziness—Diltiazem—hypertension	3.57e-05	0.000702	CcSEcCtD
Naphazoline—Somnolence—Furosemide—hypertension	3.56e-05	0.0007	CcSEcCtD
Naphazoline—Dizziness—Carvedilol—hypertension	3.54e-05	0.000695	CcSEcCtD
Naphazoline—Dizziness—Doxazosin—hypertension	3.5e-05	0.000687	CcSEcCtD
Naphazoline—Vision blurred—Lisinopril—hypertension	3.47e-05	0.000682	CcSEcCtD
Naphazoline—Dizziness—Fosinopril—hypertension	3.45e-05	0.000679	CcSEcCtD
Naphazoline—Somnolence—Losartan—hypertension	3.43e-05	0.000675	CcSEcCtD
Naphazoline—Dizziness—Eplerenone—hypertension	3.43e-05	0.000675	CcSEcCtD
Naphazoline—Asthenia—Valsartan—hypertension	3.43e-05	0.000674	CcSEcCtD
Naphazoline—Hypertension—Timolol—hypertension	3.43e-05	0.000673	CcSEcCtD
Naphazoline—Discomfort—Ramipril—hypertension	3.41e-05	0.000671	CcSEcCtD
Naphazoline—Asthenia—Olmesartan—hypertension	3.41e-05	0.00067	CcSEcCtD
Naphazoline—Dizziness—Nifedipine—hypertension	3.41e-05	0.00067	CcSEcCtD
Naphazoline—Dizziness—Verapamil—hypertension	3.39e-05	0.000667	CcSEcCtD
Naphazoline—Headache—Indapamide—hypertension	3.38e-05	0.000665	CcSEcCtD
Naphazoline—Headache—Diltiazem—hypertension	3.38e-05	0.000665	CcSEcCtD
Naphazoline—Headache—Carvedilol—hypertension	3.35e-05	0.000658	CcSEcCtD
Naphazoline—Discomfort—Timolol—hypertension	3.34e-05	0.000656	CcSEcCtD
Naphazoline—Nausea—Propranolol—hypertension	3.31e-05	0.000651	CcSEcCtD
Naphazoline—Headache—Doxazosin—hypertension	3.31e-05	0.000651	CcSEcCtD
Naphazoline—Headache—Fosinopril—hypertension	3.27e-05	0.000643	CcSEcCtD
Naphazoline—Asthenia—Clonidine—hypertension	3.27e-05	0.000642	CcSEcCtD
Naphazoline—Headache—Eplerenone—hypertension	3.25e-05	0.000639	CcSEcCtD
Naphazoline—Headache—Nifedipine—hypertension	3.23e-05	0.000634	CcSEcCtD
Naphazoline—Headache—Verapamil—hypertension	3.21e-05	0.000632	CcSEcCtD
Naphazoline—Nausea—Indapamide—hypertension	3.21e-05	0.00063	CcSEcCtD
Naphazoline—Nausea—Diltiazem—hypertension	3.21e-05	0.00063	CcSEcCtD
Naphazoline—Hyperhidrosis—Ramipril—hypertension	3.2e-05	0.000629	CcSEcCtD
Naphazoline—Asthenia—Trandolapril—hypertension	3.19e-05	0.000626	CcSEcCtD
Naphazoline—Nausea—Carvedilol—hypertension	3.18e-05	0.000624	CcSEcCtD
Naphazoline—Asthenia—Enalapril—hypertension	3.17e-05	0.000624	CcSEcCtD
Naphazoline—Dizziness—Valsartan—hypertension	3.16e-05	0.000621	CcSEcCtD
Naphazoline—Dizziness—Olmesartan—hypertension	3.14e-05	0.000618	CcSEcCtD
Naphazoline—Nausea—Doxazosin—hypertension	3.14e-05	0.000617	CcSEcCtD
Naphazoline—Hyperhidrosis—Timolol—hypertension	3.13e-05	0.000615	CcSEcCtD
Naphazoline—Asthenia—Telmisartan—hypertension	3.13e-05	0.000615	CcSEcCtD
Naphazoline—Nausea—Fosinopril—hypertension	3.1e-05	0.00061	CcSEcCtD
Naphazoline—Discomfort—Lisinopril—hypertension	3.1e-05	0.000608	CcSEcCtD
Naphazoline—Nausea—Eplerenone—hypertension	3.08e-05	0.000606	CcSEcCtD
Naphazoline—Nausea—Nifedipine—hypertension	3.06e-05	0.000602	CcSEcCtD
Naphazoline—Nausea—Verapamil—hypertension	3.05e-05	0.000599	CcSEcCtD
Naphazoline—Asthenia—Captopril—hypertension	3.04e-05	0.000598	CcSEcCtD
Naphazoline—Dizziness—Clonidine—hypertension	3.01e-05	0.000592	CcSEcCtD
Naphazoline—Headache—Valsartan—hypertension	2.99e-05	0.000588	CcSEcCtD
Naphazoline—Headache—Olmesartan—hypertension	2.98e-05	0.000585	CcSEcCtD
Naphazoline—Asthenia—Perindopril—hypertension	2.96e-05	0.000581	CcSEcCtD
Naphazoline—Asthenia—Irbesartan—hypertension	2.95e-05	0.000579	CcSEcCtD
Naphazoline—Somnolence—Ramipril—hypertension	2.94e-05	0.000579	CcSEcCtD
Naphazoline—Dizziness—Trandolapril—hypertension	2.94e-05	0.000577	CcSEcCtD
Naphazoline—Dizziness—Enalapril—hypertension	2.92e-05	0.000575	CcSEcCtD
Naphazoline—Asthenia—Hydrochlorothiazide—hypertension	2.92e-05	0.000574	CcSEcCtD
Naphazoline—Hyperhidrosis—Lisinopril—hypertension	2.9e-05	0.000571	CcSEcCtD
Naphazoline—Duloxetine—HTR2A—hypertension	2.9e-05	0.0159	CrCbGaD
Naphazoline—Dizziness—Telmisartan—hypertension	2.88e-05	0.000567	CcSEcCtD
Naphazoline—Somnolence—Timolol—hypertension	2.88e-05	0.000566	CcSEcCtD
Naphazoline—Asthenia—Furosemide—hypertension	2.87e-05	0.000565	CcSEcCtD
Naphazoline—Headache—Clonidine—hypertension	2.85e-05	0.000561	CcSEcCtD
Naphazoline—Asthenia—Betaxolol—hypertension	2.84e-05	0.000559	CcSEcCtD
Naphazoline—Nausea—Valsartan—hypertension	2.84e-05	0.000558	CcSEcCtD
Naphazoline—Nausea—Olmesartan—hypertension	2.82e-05	0.000555	CcSEcCtD
Naphazoline—Dizziness—Captopril—hypertension	2.81e-05	0.000551	CcSEcCtD
Naphazoline—Propranolol—HTR1B—hypertension	2.78e-05	0.0152	CrCbGaD
Naphazoline—Headache—Trandolapril—hypertension	2.78e-05	0.000547	CcSEcCtD
Naphazoline—Asthenia—Losartan—hypertension	2.77e-05	0.000545	CcSEcCtD
Naphazoline—Headache—Enalapril—hypertension	2.77e-05	0.000545	CcSEcCtD
Naphazoline—Headache—Telmisartan—hypertension	2.73e-05	0.000537	CcSEcCtD
Naphazoline—Dizziness—Perindopril—hypertension	2.72e-05	0.000535	CcSEcCtD
Naphazoline—Dizziness—Irbesartan—hypertension	2.71e-05	0.000533	CcSEcCtD
Naphazoline—Nausea—Clonidine—hypertension	2.7e-05	0.000531	CcSEcCtD
Naphazoline—Dizziness—Hydrochlorothiazide—hypertension	2.69e-05	0.000529	CcSEcCtD
Naphazoline—Somnolence—Lisinopril—hypertension	2.67e-05	0.000525	CcSEcCtD
Naphazoline—Headache—Captopril—hypertension	2.66e-05	0.000522	CcSEcCtD
Naphazoline—Dizziness—Furosemide—hypertension	2.65e-05	0.00052	CcSEcCtD
Naphazoline—Nausea—Trandolapril—hypertension	2.64e-05	0.000518	CcSEcCtD
Naphazoline—Nausea—Enalapril—hypertension	2.63e-05	0.000516	CcSEcCtD
Naphazoline—Dizziness—Betaxolol—hypertension	2.62e-05	0.000515	CcSEcCtD
Naphazoline—Propranolol—CYP3A5—hypertension	2.62e-05	0.0143	CrCbGaD
Naphazoline—Nausea—Telmisartan—hypertension	2.59e-05	0.000509	CcSEcCtD
Naphazoline—Headache—Perindopril—hypertension	2.58e-05	0.000507	CcSEcCtD
Naphazoline—Headache—Irbesartan—hypertension	2.57e-05	0.000505	CcSEcCtD
Naphazoline—Dizziness—Losartan—hypertension	2.55e-05	0.000502	CcSEcCtD
Naphazoline—Headache—Hydrochlorothiazide—hypertension	2.55e-05	0.000501	CcSEcCtD
Naphazoline—Nausea—Captopril—hypertension	2.52e-05	0.000495	CcSEcCtD
Naphazoline—Headache—Furosemide—hypertension	2.51e-05	0.000493	CcSEcCtD
Naphazoline—Headache—Betaxolol—hypertension	2.48e-05	0.000488	CcSEcCtD
Naphazoline—Propranolol—ADRB1—hypertension	2.46e-05	0.0135	CrCbGaD
Naphazoline—Nausea—Perindopril—hypertension	2.45e-05	0.000481	CcSEcCtD
Naphazoline—Nausea—Irbesartan—hypertension	2.44e-05	0.000479	CcSEcCtD
Naphazoline—Headache—Losartan—hypertension	2.42e-05	0.000476	CcSEcCtD
Naphazoline—Nausea—Hydrochlorothiazide—hypertension	2.42e-05	0.000475	CcSEcCtD
Naphazoline—Nausea—Furosemide—hypertension	2.38e-05	0.000467	CcSEcCtD
Naphazoline—Asthenia—Ramipril—hypertension	2.38e-05	0.000467	CcSEcCtD
Naphazoline—Nausea—Betaxolol—hypertension	2.35e-05	0.000463	CcSEcCtD
Naphazoline—Asthenia—Timolol—hypertension	2.32e-05	0.000457	CcSEcCtD
Naphazoline—Nausea—Losartan—hypertension	2.29e-05	0.000451	CcSEcCtD
Naphazoline—Dizziness—Ramipril—hypertension	2.19e-05	0.00043	CcSEcCtD
Naphazoline—Asthenia—Lisinopril—hypertension	2.16e-05	0.000424	CcSEcCtD
Naphazoline—Dizziness—Timolol—hypertension	2.14e-05	0.000421	CcSEcCtD
Naphazoline—Headache—Ramipril—hypertension	2.08e-05	0.000408	CcSEcCtD
Naphazoline—Propranolol—ADRB2—hypertension	2.07e-05	0.0113	CrCbGaD
Naphazoline—Headache—Timolol—hypertension	2.03e-05	0.000399	CcSEcCtD
Naphazoline—Dizziness—Lisinopril—hypertension	1.99e-05	0.00039	CcSEcCtD
Naphazoline—Nausea—Ramipril—hypertension	1.97e-05	0.000387	CcSEcCtD
Naphazoline—Nausea—Timolol—hypertension	1.92e-05	0.000378	CcSEcCtD
Naphazoline—Headache—Lisinopril—hypertension	1.88e-05	0.00037	CcSEcCtD
Naphazoline—Nausea—Lisinopril—hypertension	1.78e-05	0.000351	CcSEcCtD
Naphazoline—Propranolol—CYP1A1—hypertension	1.78e-05	0.00972	CrCbGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CXCL8—hypertension	1.42e-06	3.9e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HTR2A—hypertension	1.41e-06	3.87e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EDN1—hypertension	1.41e-06	3.87e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CALM1—hypertension	1.41e-06	3.86e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TGFBR2—hypertension	1.41e-06	3.86e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—C3—hypertension	1.41e-06	3.86e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APOE—hypertension	1.4e-06	3.85e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—LEP—hypertension	1.4e-06	3.85e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCL5—hypertension	1.4e-06	3.84e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GNB3—hypertension	1.39e-06	3.83e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CAV1—hypertension	1.39e-06	3.82e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APOA1—hypertension	1.39e-06	3.81e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AVP—hypertension	1.37e-06	3.78e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—KDR—hypertension	1.37e-06	3.77e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PDGFB—hypertension	1.37e-06	3.76e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—MTHFR—hypertension	1.37e-06	3.75e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—LPL—hypertension	1.37e-06	3.75e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PPARG—hypertension	1.36e-06	3.75e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—RHOA—hypertension	1.36e-06	3.74e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—FGFR1—hypertension	1.36e-06	3.74e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GNAS—hypertension	1.36e-06	3.73e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—H2AFX—hypertension	1.36e-06	3.72e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RPS6KB1—hypertension	1.35e-06	3.72e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PDGFRB—hypertension	1.35e-06	3.72e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PIK3R1—hypertension	1.35e-06	3.71e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—POMC—hypertension	1.34e-06	3.7e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HIF1A—hypertension	1.34e-06	3.68e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PPARA—hypertension	1.34e-06	3.68e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—INS—hypertension	1.34e-06	3.68e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADCY5—hypertension	1.34e-06	3.67e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AGT—hypertension	1.34e-06	3.67e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—AKT1—hypertension	1.33e-06	3.65e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOB—hypertension	1.33e-06	3.65e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PRKCG—hypertension	1.33e-06	3.65e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PTK2—hypertension	1.32e-06	3.64e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—FN1—hypertension	1.32e-06	3.63e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—F2—hypertension	1.32e-06	3.63e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PRKCB—hypertension	1.32e-06	3.63e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PRKCA—hypertension	1.32e-06	3.62e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ITGB3—hypertension	1.32e-06	3.62e-05	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CXCL8—hypertension	1.32e-06	3.62e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CALM1—hypertension	1.31e-06	3.61e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—LEP—hypertension	1.31e-06	3.6e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APOE—hypertension	1.31e-06	3.6e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—YWHAZ—hypertension	1.31e-06	3.59e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EDN1—hypertension	1.31e-06	3.59e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—AGT—hypertension	1.3e-06	3.57e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCL5—hypertension	1.3e-06	3.56e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CAV1—hypertension	1.3e-06	3.56e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APOA1—hypertension	1.29e-06	3.56e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NOTCH1—hypertension	1.29e-06	3.55e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NGF—hypertension	1.29e-06	3.55e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SPP1—hypertension	1.29e-06	3.55e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CXCL8—hypertension	1.29e-06	3.54e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—KDR—hypertension	1.28e-06	3.52e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TP53—hypertension	1.28e-06	3.51e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CALM1—hypertension	1.28e-06	3.51e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—APOE—hypertension	1.27e-06	3.49e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LPL—hypertension	1.27e-06	3.49e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CAV1—hypertension	1.26e-06	3.46e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—H2AFX—hypertension	1.26e-06	3.46e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCR5—hypertension	1.26e-06	3.46e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PRKCD—hypertension	1.26e-06	3.46e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RPS6KB1—hypertension	1.26e-06	3.45e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PDGFRB—hypertension	1.26e-06	3.45e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—APOA1—hypertension	1.26e-06	3.45e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADCY5—hypertension	1.24e-06	3.41e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PRKCB—hypertension	1.23e-06	3.39e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—F2—hypertension	1.23e-06	3.39e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—FN1—hypertension	1.23e-06	3.39e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PRKCG—hypertension	1.23e-06	3.39e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HTR2A—hypertension	1.23e-06	3.38e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—C3—hypertension	1.23e-06	3.38e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ALB—hypertension	1.23e-06	3.37e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ITGB3—hypertension	1.23e-06	3.37e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PRKCA—hypertension	1.23e-06	3.37e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—YWHAZ—hypertension	1.22e-06	3.34e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NOTCH1—hypertension	1.21e-06	3.32e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—POMC—hypertension	1.2e-06	3.31e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NGF—hypertension	1.2e-06	3.3e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SPP1—hypertension	1.2e-06	3.3e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—INS—hypertension	1.2e-06	3.29e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PDGFB—hypertension	1.2e-06	3.29e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CXCL8—hypertension	1.2e-06	3.29e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FGFR1—hypertension	1.19e-06	3.27e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCL2—hypertension	1.18e-06	3.24e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—NOS3—hypertension	1.17e-06	3.22e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PIK3R1—hypertension	1.17e-06	3.22e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HIF1A—hypertension	1.17e-06	3.22e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCR5—hypertension	1.17e-06	3.21e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PRKCD—hypertension	1.17e-06	3.21e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AGT—hypertension	1.17e-06	3.21e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IGF1—hypertension	1.16e-06	3.18e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AKT2—hypertension	1.16e-06	3.18e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—EGFR—hypertension	1.15e-06	3.17e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CALM1—hypertension	1.15e-06	3.16e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APOE—hypertension	1.14e-06	3.14e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—LEP—hypertension	1.14e-06	3.14e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HTR2A—hypertension	1.14e-06	3.14e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—C3—hypertension	1.14e-06	3.14e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CAV1—hypertension	1.13e-06	3.12e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APOA1—hypertension	1.13e-06	3.11e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—POMC—hypertension	1.12e-06	3.09e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—KDR—hypertension	1.12e-06	3.08e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—INS—hypertension	1.12e-06	3.07e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PDGFB—hypertension	1.11e-06	3.05e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PPARG—hypertension	1.11e-06	3.04e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FGFR1—hypertension	1.11e-06	3.04e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCL2—hypertension	1.1e-06	3.02e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SERPINE1—hypertension	1.1e-06	3.02e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—POMC—hypertension	1.09e-06	3e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HIF1A—hypertension	1.09e-06	2.99e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—INS—hypertension	1.09e-06	2.99e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AGT—hypertension	1.09e-06	2.98e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IGF1—hypertension	1.08e-06	2.97e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AKT2—hypertension	1.08e-06	2.97e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—AKT1—hypertension	1.08e-06	2.97e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—F2—hypertension	1.08e-06	2.97e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FN1—hypertension	1.08e-06	2.97e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PRKCB—hypertension	1.08e-06	2.97e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—EGFR—hypertension	1.08e-06	2.96e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PTGS2—hypertension	1.07e-06	2.95e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CALM1—hypertension	1.07e-06	2.93e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—FGF2—hypertension	1.06e-06	2.93e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOE—hypertension	1.06e-06	2.92e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LEP—hypertension	1.06e-06	2.92e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—RHOA—hypertension	1.06e-06	2.92e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NOTCH1—hypertension	1.06e-06	2.9e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CAV1—hypertension	1.05e-06	2.89e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOA1—hypertension	1.05e-06	2.89e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3R1—hypertension	1.05e-06	2.88e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NOS3—hypertension	1.05e-06	2.88e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—KDR—hypertension	1.04e-06	2.86e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SERPINE1—hypertension	1.03e-06	2.82e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PRKCB—hypertension	1e-06	2.76e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—F2—hypertension	1e-06	2.76e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FN1—hypertension	1e-06	2.76e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ALB—hypertension	9.96e-07	2.74e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—FGF2—hypertension	9.94e-07	2.73e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RHOA—hypertension	9.91e-07	2.72e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—RELA—hypertension	9.88e-07	2.72e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—POMC—hypertension	9.83e-07	2.7e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NOTCH1—hypertension	9.81e-07	2.7e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3R1—hypertension	9.81e-07	2.69e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NOS3—hypertension	9.81e-07	2.69e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—INS—hypertension	9.78e-07	2.69e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MTOR—hypertension	9.69e-07	2.66e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCL2—hypertension	9.62e-07	2.64e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3R1—hypertension	9.53e-07	2.62e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—NOS3—hypertension	9.53e-07	2.62e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IGF1—hypertension	9.46e-07	2.6e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AKT2—hypertension	9.45e-07	2.6e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—EGFR—hypertension	9.41e-07	2.59e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PTEN—hypertension	9.36e-07	2.57e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CXCL8—hypertension	9.31e-07	2.56e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RELA—hypertension	9.23e-07	2.54e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—POMC—hypertension	9.13e-07	2.51e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—INS—hypertension	9.08e-07	2.5e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MTOR—hypertension	9.05e-07	2.49e-05	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—AKT1—hypertension	9e-07	2.47e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SERPINE1—hypertension	8.98e-07	2.47e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCL2—hypertension	8.94e-07	2.46e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—EP300—hypertension	8.92e-07	2.45e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL6—hypertension	8.86e-07	2.43e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IGF1—hypertension	8.79e-07	2.41e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AKT2—hypertension	8.78e-07	2.41e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—EGFR—hypertension	8.74e-07	2.4e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PTGS2—hypertension	8.71e-07	2.39e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CXCL8—hypertension	8.7e-07	2.39e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FGF2—hypertension	8.69e-07	2.39e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RHOA—hypertension	8.66e-07	2.38e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3R1—hypertension	8.57e-07	2.36e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NOS3—hypertension	8.57e-07	2.36e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MMP9—hypertension	8.42e-07	2.31e-05	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—AKT1—hypertension	8.4e-07	2.31e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CDKN1A—hypertension	8.39e-07	2.31e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PTEN—hypertension	8.37e-07	2.3e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SERPINE1—hypertension	8.34e-07	2.29e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL6—hypertension	8.27e-07	2.27e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MAPK8—hypertension	8.19e-07	2.25e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—AKT1—hypertension	8.17e-07	2.24e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FGF2—hypertension	8.08e-07	2.22e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RELA—hypertension	8.07e-07	2.22e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RHOA—hypertension	8.05e-07	2.21e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EP300—hypertension	7.99e-07	2.19e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3R1—hypertension	7.97e-07	2.19e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NOS3—hypertension	7.97e-07	2.19e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MTOR—hypertension	7.91e-07	2.17e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MMP9—hypertension	7.87e-07	2.16e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CDKN1A—hypertension	7.84e-07	2.15e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PTEN—hypertension	7.82e-07	2.15e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SRC—hypertension	7.77e-07	2.13e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MAPK8—hypertension	7.65e-07	2.1e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—AKT1—hypertension	7.63e-07	2.1e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCL8—hypertension	7.61e-07	2.09e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PTEN—hypertension	7.6e-07	2.09e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—VEGFA—hypertension	7.56e-07	2.08e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RELA—hypertension	7.5e-07	2.06e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EP300—hypertension	7.46e-07	2.05e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MTOR—hypertension	7.35e-07	2.02e-05	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—AKT1—hypertension	7.35e-07	2.02e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SRC—hypertension	7.25e-07	1.99e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—EP300—hypertension	7.25e-07	1.99e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6—hypertension	7.23e-07	1.99e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCL8—hypertension	7.07e-07	1.94e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—VEGFA—hypertension	7.07e-07	1.94e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MYC—hypertension	6.96e-07	1.91e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TGFB1—hypertension	6.94e-07	1.91e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MMP9—hypertension	6.88e-07	1.89e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CDKN1A—hypertension	6.85e-07	1.88e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PTEN—hypertension	6.84e-07	1.88e-05	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—AKT1—hypertension	6.83e-07	1.88e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EGFR—hypertension	6.81e-07	1.87e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6—hypertension	6.72e-07	1.85e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MAPK8—hypertension	6.69e-07	1.84e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—AKT1—hypertension	6.67e-07	1.83e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EP300—hypertension	6.52e-07	1.79e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MYC—hypertension	6.5e-07	1.79e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TGFB1—hypertension	6.49e-07	1.78e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MMP9—hypertension	6.39e-07	1.76e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CDKN1A—hypertension	6.37e-07	1.75e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EGFR—hypertension	6.36e-07	1.75e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PTEN—hypertension	6.35e-07	1.75e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SRC—hypertension	6.34e-07	1.74e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MAPK8—hypertension	6.22e-07	1.71e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—AKT1—hypertension	6.2e-07	1.7e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—VEGFA—hypertension	6.18e-07	1.7e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EP300—hypertension	6.06e-07	1.67e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SRC—hypertension	5.89e-07	1.62e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—VEGFA—hypertension	5.74e-07	1.58e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TP53—hypertension	5.72e-07	1.57e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MYC—hypertension	5.68e-07	1.56e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TGFB1—hypertension	5.67e-07	1.56e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EGFR—hypertension	5.56e-07	1.53e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—AKT1—hypertension	5.39e-07	1.48e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TP53—hypertension	5.34e-07	1.47e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MYC—hypertension	5.28e-07	1.45e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TGFB1—hypertension	5.27e-07	1.45e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6—hypertension	5.23e-07	1.44e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EGFR—hypertension	5.16e-07	1.42e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6—hypertension	4.89e-07	1.34e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AKT1—hypertension	4.83e-07	1.33e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TP53—hypertension	4.67e-07	1.28e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AKT1—hypertension	4.51e-07	1.24e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—AKT1—hypertension	4.38e-07	1.2e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TP53—hypertension	4.34e-07	1.19e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6—hypertension	4.27e-07	1.17e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6—hypertension	3.97e-07	1.09e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AKT1—hypertension	3.94e-07	1.08e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AKT1—hypertension	3.66e-07	1.01e-05	CbGpPWpGaD
